Chronic News and Research

RSS

Antibiotics could be the cause of many allergies

Allergies making your life miserable? Tired of popping antihistamines like candy? Can't go anywhere without your inhaler? The real problem may not be your stuffed-up head. It could be the microbes in your gut.

27 May 2004

Obesity affects women's employment success

Obesity contributes to various chronic medical problems, but new research on current and former welfare recipients indicates that obesity also affects women's employment success.

27 May 2004

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Results of a new study published in the current issue of the New England Journal of Medicine show that in patients who have chronic hepatitis C, genotype 1 -- the most common form of the disease and difficult to treat successfully -- non-Hispanic whites achieved one of the highest response rates reported to date, but response rates in African Americans were significantly lower.

27 May 2004

Australian university offers free Chinese medicine treatment

With winter fast approaching, RMIT University is helping people to beat coughs, colds and other winter nasties with a free introductory offer for Chinese medicine treatment.

27 May 2004

17,000 immigrant children and parents in Washington state have lost public health coverage

Since the elimination of a public medical assistance program in 2002, more than 17,000 immigrant children and parents in Washington state have lost public health coverage as of April 2004.

27 May 2004

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.

27 May 2004

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Imagine suffering frequent, extreme and disabling mood swings that won’t go away despite years of different treatments and diagnoses.

26 May 2004

Scientific evidence links mold in homes and buildings to people with chronic asthma symptoms

Scientific evidence links mold and other factors related to damp conditions in homes and buildings to asthma symptoms in some people with the chronic disorder, as well as to coughing, wheezing, and upper respiratory tract symptoms in otherwise healthy people, says a new report from the Institute of Medicine of the National Academies.

25 May 2004

Zengen announces positive results of treatment for vaginal yeast infection

Zengen Inc. announced today positive phase I/II results for its proprietary molecule CZEN-002 for the treatment of vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection.

25 May 2004

$3.5 million grant to develop AIDS vaccinations

Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS.

25 May 2004

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

ALTANA AG’s investigational anti-inflammatory medicine roflumilast improved lung function in patients with Chronic Obstructive Pulmonary Disease (COPD) according to a placebo controlled study presented at the annual meeting of the American Thoracic Society (ATS).

25 May 2004

Some smokers may be genetically predisposed to chronic obstructive pulmonary disease

In her study, Ohar looked at more than 500 men and women age 40 and older who had smoked 20 years or more. She found that a variation of the macrophage scavenger receptor gene (MSR-1) is related to the development of airways obstruction in some patients who smoke cigarettes.

25 May 2004

Vasamed announces patent for a novel pulse oximeter

Vasamed, developer and supplier of hemodynamic monitoring products, announced that the U.S. Patent and Trademark Office granted it a method patent for a novel pulse oximeter that incorporates signals from a laser Doppler velocimeter (LDV) and an impedance cardiograph (ICG) to accomplish the measurement of oxygen saturation.

25 May 2004

Pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in emergency

A study presented today at the 100th International Conference of the American Thoracic Society in Orlando shows pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in the emergency department (ED) or being admitted into the hospital.

25 May 2004

CRT devices used in combination with optimized pharmacologic therapy (OPT) significantly impact patient's quality and length of life

UI Heart Care researchers are among the first in the nation to evaluate the effectiveness of cardiac resynchronization therapy (CRT) devices to reduce the risk of mortality and hospitalization in advanced heart failure patients.

25 May 2004

Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it

“Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it,” says Mariell Jessup, MD, Professor of Medicine and Medical Director of the Heart Failure and Transplantation Program at the Hospital of the University of Pennsylvania (HUP).

24 May 2004

Intensive exercising after menopause may reduce bone loss

Early postmenopausal women with osteoporosis who participate in an intense exercise program may experience reduced bone loss, reduced back pain, and lower cholesterol levels, according to an article in the May 24 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

24 May 2004

Trial shows Daclizumab therapy improves multiple sclerosis outcome

A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements.

24 May 2004

Revolutionary self healing bandage that uses the patient's own cells

A revolutionary type of 'self healing' bandage that uses the patient's own cells is being developed. The technique has already been tried successfully on patients with diabetic ulcers and in the long-term could offer a more effective, quicker and cost efficient way of treating many types of slow-healing wounds such as pressure ulcers.

24 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Chronic News and Research

Antibiotics could be the cause of many allergies

Obesity affects women's employment success

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Australian university offers free Chinese medicine treatment

17,000 immigrant children and parents in Washington state have lost public health coverage

Human Genome Sciences has begun dosing patients with chronic hep C drug

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Scientific evidence links mold in homes and buildings to people with chronic asthma symptoms

Zengen announces positive results of treatment for vaginal yeast infection

$3.5 million grant to develop AIDS vaccinations

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

Some smokers may be genetically predisposed to chronic obstructive pulmonary disease

Vasamed announces patent for a novel pulse oximeter

Pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in emergency

CRT devices used in combination with optimized pharmacologic therapy (OPT) significantly impact patient's quality and length of life

Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it

Intensive exercising after menopause may reduce bone loss

Trial shows Daclizumab therapy improves multiple sclerosis outcome

Revolutionary self healing bandage that uses the patient's own cells

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News